Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard treatment for reducing the incidence of strokes and systemic emboli in patients with nonvalvular atrial fibrillation ...
The ratio of early transmitral flow velocity (E) to early diastolic mitral annular velocity ... of clinical outcome in patients with nonvalvular atrial fibrillation.